These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 23803027)
21. Efficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysis. Fan XL; Cai GP; Zhu LL; Ding GM Drug Des Devel Ther; 2015; 9():5925-32. PubMed ID: 26604690 [TBL] [Abstract][Full Text] [Related]
22. Quantitative (201)thallium scintigraphy for prediction of histological response to neoadjuvant chemotherapy in osteosarcoma; systematic review and meta-analysis. Kubo T; Shimose S; Fujimori J; Furuta T; Ochi M Surg Oncol; 2015 Sep; 24(3):194-9. PubMed ID: 26092710 [TBL] [Abstract][Full Text] [Related]
23. Prognostic value of microRNAs in osteosarcoma: A meta-analysis. Kim YH; Goh TS; Lee CS; Oh SO; Kim JI; Jeung SH; Pak K Oncotarget; 2017 Jan; 8(5):8726-8737. PubMed ID: 28060730 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma. Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164 [TBL] [Abstract][Full Text] [Related]
25. A meta-analysis on the association of HER-2 overexpression with prognosis in human osteosarcoma. Li YG; Geng X Eur J Cancer Care (Engl); 2010 May; 19(3):313-6. PubMed ID: 19709164 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy. Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431 [TBL] [Abstract][Full Text] [Related]
27. Correlation of the Rac1/RhoA pathway with ezrin expression in osteosarcoma. Chiappetta C; Leopizzi M; Censi F; Puggioni C; Petrozza V; Rocca CD; Di Cristofano C Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):162-70. PubMed ID: 24614149 [TBL] [Abstract][Full Text] [Related]
28. pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma. Thanapprapasr K; Nartthanarung A; Thanapprapasr D; Jinawath A PLoS One; 2017; 12(8):e0182989. PubMed ID: 28846700 [TBL] [Abstract][Full Text] [Related]
29. The β5/focal adhesion kinase/glycogen synthase kinase 3β integrin pathway in high-grade osteosarcoma: a protein expression profile predictive of response to neoadjuvant chemotherapy. Le Guellec S; Moyal EC; Filleron T; Delisle MB; Chevreau C; Rubie H; Castex MP; de Gauzy JS; Bonnevialle P; Gomez-Brouchet A Hum Pathol; 2013 Oct; 44(10):2149-58. PubMed ID: 23845472 [TBL] [Abstract][Full Text] [Related]
30. The Prognostic Role of Ezrin and HER2/neu Expression in Osteosarcoma. Abdou AG; Kandil M; Asaad NY; Dawoud MM; Shahin AA; Abd Eldayem AF Appl Immunohistochem Mol Morphol; 2016; 24(5):355-63. PubMed ID: 26067138 [TBL] [Abstract][Full Text] [Related]
31. Examination of the cutoff value of postchemotherapy increase in tumor volume as a predictor of subsequent oncologic events in stage IIB osteosarcoma. Jeon DG; Kong CB; Cho WH; Song WS; Cho SH; Choi SW; Lee SY J Surg Oncol; 2014 Mar; 109(3):275-9. PubMed ID: 24243222 [TBL] [Abstract][Full Text] [Related]
32. Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell. Di Cristofano C; Leopizzi M; Miraglia A; Sardella B; Moretti V; Ferrara A; Petrozza V; Della Rocca C Mod Pathol; 2010 Jul; 23(7):1012-20. PubMed ID: 20348881 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2. Cui SQ; Wang H Tumour Biol; 2015 Sep; 36(9):6949-58. PubMed ID: 25854173 [TBL] [Abstract][Full Text] [Related]
34. Tumor volume change after chemotheraphy as a predictive factor of disease free survival for osteosarcoma. Moon SH; Shin KH; Suh JS; Yang WI; Noh JK; Hahn SB Yonsei Med J; 2005 Feb; 46(1):119-24. PubMed ID: 15744814 [TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis. Jiao G; Ren T; Lu Q; Sun Y; Lou Z; Peng X; Liang W; Guo W Tumour Biol; 2013 Oct; 34(5):2489-95. PubMed ID: 23857285 [TBL] [Abstract][Full Text] [Related]
36. Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis. Guo S; Bai R; Zhao W; Wang Y; Zhao Z; Feng W Tumour Biol; 2014 Jan; 35(1):469-73. PubMed ID: 23959472 [TBL] [Abstract][Full Text] [Related]
37. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461 [TBL] [Abstract][Full Text] [Related]
38. Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients. Nataraj V; Batra A; Rastogi S; Khan SA; Sharma MC; Vishnubhatla S; Bakhshi S J Surg Oncol; 2015 Nov; 112(6):662-8. PubMed ID: 26381138 [TBL] [Abstract][Full Text] [Related]
39. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival. Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470 [TBL] [Abstract][Full Text] [Related]
40. P-glycoprotein binds to ezrin at amino acid residues 149-242 in the FERM domain and plays a key role in the multidrug resistance of human osteosarcoma. Brambilla D; Zamboni S; Federici C; Lugini L; Lozupone F; De Milito A; Cecchetti S; Cianfriglia M; Fais S Int J Cancer; 2012 Jun; 130(12):2824-34. PubMed ID: 21780101 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]